First Capital Advisors Group, Llc. Passage Bio, Inc. Transaction History
First Capital Advisors Group, Llc.
- $188 Million
- Q2 2023
A detailed history of First Capital Advisors Group, Llc. transactions in Passage Bio, Inc. stock. As of the latest transaction made, First Capital Advisors Group, Llc. holds 23 shares of PASG stock, worth $13. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23Holding current value
$13% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PASG
# of Institutions
47Shares Held
38.7MCall Options Held
7.7KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA9.82MShares$5.89 Million0.16% of portfolio
-
Lynx1 Capital Management LP San Juan, PR8.43MShares$5.06 Million2.11% of portfolio
-
Vestal Point Capital, LP New York, NY6.1MShares$3.66 Million0.32% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY2.5MShares$1.5 Million1.8% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.46MShares$1.47 Million0.02% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $32.7M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...